European Archives - Page 584 of 1232 - European Medical Journal

EMJ Hematology 10.1 2022 Feature Image

EMJ Hematology 10.1 2022

Welcome to our latest issue of EMJ Hematology, which brings you quality content on the latest developments in the field and a review of the European Hematology Association (EHA) 2022 Hybrid Congress, with key highlights from the event. Featured articles include a review of the social impact and quality of life for patients with β-thalassaemia, and an article on how helical tomotherapy may be used as a valid and effective treatment for compressive atelectasis due to extramedullary haematopoiesis.

EMJ Hematology 10.1 2022 Feature Image

Zamtocabtagene Autoleucel (MB-CART2019.1): An Investigational CAR-T Cell Product with Tandem Targeting of CD19 and CD20 as a Potential Treatment Option for Patients with Relapsed/ Refractory B Cell Non-Hodgkin Lymphoma

Presenting at the European Hematology Association (EHA) 2022 Congress, Peter Borchmann from the University of Cologne, Germany…

EMJ Hematology 10.1 2022 Feature Image

Exploring a Role for Mitapivat in Children with Pyruvate Kinase Deficiency

Three posters presented at the European Hematology Association (EHA) 2022 Hybrid Congress focused on the role of mitapivat in the…

EMJ Hematology 10.1 2022 Feature Image

Review of the European Hematology Association 2022 Hybrid Congress

THE EUROPEAN Hematology Association (EHA) successfully brought together clinicians and researchers from all over the world to share the latest advances in the field of haematology in its 27th Annual Congress, and its first ever hybrid congress.

EMJ Hematology 10.1 2022 Feature Image

Paediatric Von Willebrand Disease-Associated Angiodysplasia

Von Willebrand disease (VWD) was first described in 1926 by Erik von Willebrand when he cared for a family member…

EMJ Hematology 10.1 2022 Feature Image

The Impact of Hormone Therapy on Venous Thromboembolism Risk in Women

MILLIONS of women across the world opt for hormone-based therapies for contraception, and as a replacement therapy for relieving symptoms…

Feature Image Cardio Supp 3

Personalised Approach to Atherosclerotic Cardiovascular Disease: The Future is Here

This plenary session began with a focus on cutting edge research into the role of the immune system in atherosclerotic cardiovascular dise…

Season finale: MMR and vaccines past, present and future

As Helena and Marc wrap up this season, they’re joined by Mike Watson, CEO of Mevox, to discuss past present and future of vaccines.

Sanofi Genzyme’s Bill Sibold on preventing future health inequities

Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.

ABPI wins prestigious PIF TICK status

The Association of the British Pharmaceutical Industry (ABPI) has been awarded PIF TICK trusted healthcare information creator status by the Patient Information Forum, in recognition of its commitment to providing clear, accurate information for patients and the public